• Gastrin I: Precision in Gastric Acid Secretion Pathway Resea

  2026-04-24

  Human Gastrin I peptide empowers high-fidelity modeling of gastric acid secretion mechanisms in advanced in vitro and organoid systems. This article details optimized experimental workflows, troubleshooting strategies, and direct links to breakthrough protocols, enabling researchers to leverage Gastrin I for gastrointestinal physiology studies and translational disorder research.

• Protease Inhibitor Cocktail: Plant Protein Stability Redefin

  2026-04-24

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) provides robust, broad-spectrum inhibition of endogenous plant proteases, ensuring high protein stability in plant cell and tissue extracts. Its unique composition, optimized for plant systems and free of EDTA, preserves labile protein modifications and enables reliable downstream analyses such as Western blotting. This dossier details its mechanistic rationale, evidence base, workflow integration, and key limitations.

• Viral Targeting of RIPK3: Mechanisms Regulating Necroptosis

  2026-04-23

  Liu et al. reveal that a class of orthopoxvirus proteins acts as viral inducers of degradation (vIRD), promoting ubiquitin-mediated destruction of the necroptosis adaptor RIPK3. This mechanism critically regulates inflammation and pathogenesis during viral infection, providing new insights into host-pathogen interactions and potential experimental workflows.

• Dextrose (D-glucose): Powering Glucose Metabolism Research

  2026-04-23

  Dextrose (D-glucose) is an indispensable research tool for dissecting glucose metabolism and immunometabolic dynamics, especially under conditions of hypoxia and nutrient competition in the tumor microenvironment. Leveraging high-purity D-glucose from APExBIO streamlines experimental reliability and enables translational insights into cancer and immune cell energetics.

• MK 0893: Structural Insights and Translational Protocols in

  2026-04-22

  Explore the advanced structural biology and translational protocols of MK 0893, a potent glucagon receptor antagonist. This article uniquely bridges molecular interaction insights with practical assay implementation for type 2 diabetes research.

• CA-074 Me: Optimizing Cathepsin B Inhibition in Cell Death A

  2026-04-22

  CA-074 Me enables precise dissection of lysosomal cathepsin B’s role in necroptosis, apoptosis, and inflammation, offering robust selectivity and cell permeability. This article details advanced workflows, troubleshooting, and protocol refinements, directly connecting recent mechanistic insights to actionable research strategies.

• Nilotinib (AMN-107): Quantitative Assay Design for BCR-ABL a

  2026-04-21

  Explore how Nilotinib (AMN-107) enables precise quantitative analysis of BCR-ABL and KIT signaling in chronic myeloid leukemia research. This article introduces advanced, evidence-based assay strategies and highlights essential insights from recent methodological breakthroughs.

• High-Dose Bifendate Induces Acute Hypertriglyceridemia in Ro

  2026-04-21

  This study demonstrates that high oral doses of bifendate (DDB), a synthetic derivative of Schisandrin C, sharply increase serum and hepatic triglyceride levels in rabbits and mice. The findings establish a reproducible animal model for acute hypertriglyceridemia and highlight important safety and mechanistic considerations for researchers employing bifendate in hepatic and metabolic studies.

• Dronedarone (Multaq): Applied Workflows for Atrial Fibrillat

  2026-04-20

  Dronedarone (Multaq) from APExBIO stands out for its high purity and workflow-ready solubility, making it ideal for modeling atrial fibrillation and flutter in preclinical research. This guide translates cutting-edge findings into clear protocols, troubleshooting strategies, and evidence-based application tips for advanced cardiac arrhythmia pharmacology.

• Coronavirus Macrodomains Counter PARP-Mediated Antiviral Def

  2026-04-20

  This study reveals that the coronavirus macrodomain is critical for viral evasion of host poly (ADP-ribose) polymerase (PARP)-mediated inhibition and for suppressing interferon responses. By dissecting the molecular interplay between host PARPs and the viral macrodomain, the research provides mechanistic insights with implications for antiviral strategy design.

• PD0325901: MEK Inhibitor Workflows for Cancer and Stem Cell

  2026-04-19

  PD0325901 empowers precise MEK pathway inhibition in cancer and stem cell models, enabling robust analysis of cell fate, apoptosis, and tumor suppression. This guide delivers actionable protocols, troubleshooting tips, and workflow enhancements for maximizing PD0325901’s impact in experimental settings.

• Dual-Fluorescence Cy5-labeled mRNA: Transforming Quantitativ

  2026-04-18

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) revolutionizes quantitative mRNA delivery and translation efficiency assays with dual-fluorescence and Cap 1 innovation. Distinct from prior reviews, this article bridges practical assay design with state-of-the-art nanoparticle insights.

• Palonosetron in CINV: Clinical Advances and Translational Re

  2026-04-17

  This article reviews Ruhlmann & Herrstedt's comprehensive evaluation of palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomiting (CINV). The paper provides mechanistic insights, comparative efficacy data, and clinical guidance relevant to researchers studying chemotherapeutic regimens, including those featuring agents such as Irinotecan.

• ATS-9R: Precision Gene Silencing in Adipocytes for Obesity R

  2026-04-16

  ATS-9R (Adipocyte-targeting sequence-9-arginine) enables highly specific, efficient non-viral gene delivery to white adipose tissue, transforming workflows in obesity and diabetes research. Backed by translational evidence and robust performance data, this APExBIO solution streamlines gene silencing for metabolic disease modeling with unrivaled tissue selectivity.

• Protease and Phosphatase Inhibitor Cocktail: Precision in Pr

  2026-04-15

  Unlock unparalleled protein integrity in your research with the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This advanced, EDTA-free formulation from APExBIO empowers reliable preservation of phosphorylation and post-translational modifications during extraction, supporting workflows from cell signaling to proteomics.

445 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page